Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 DiabetesHongmei Zhao, Seng H. Cheng(Pfizer (United States))DiabetesApril 30, 200710.2337/db06-0719Cited by 239SaveCiteExport RISWatch citationsRelated PapersSubstrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease|PLoS ONE|2010|72